Predictors of 1-year visual outcome in neovascular age-related macular degeneration following intravitreal ranibizumab treatment

Sara B Bloch; Morten la Cour; Birgit Sander; Louise K H Hansen; Josefine Fuchs; Henrik Lund-Andersen; Michael Larsen

doi:10.1111/j.1755-3768.2011.02268.x

Predictors of 1-year visual outcome in neovascular age-related macular degeneration following intravitreal ranibizumab treatment

Sara B Bloch, Morten la Cour, Birgit Sander, Louise K H Hansen, Josefine Fuchs, Henrik Lund-Andersen, Michael Larsen

Department of Ophthalmology

52 Citations (Scopus)

Abstract

To describe predictors of visual outcome in patients treated with intravitreal ranibizumab for choroidal neovascularisation (CNV) in age-related macular degeneration (AMD).

Original language	English
Journal	Acta Ophthalmologica
Volume	91
Issue number	1
Pages (from-to)	42-7
Number of pages	6
ISSN	1755-375X
DOIs	https://doi.org/10.1111/j.1755-3768.2011.02268.x
Publication status	Published - Feb 2013

Keywords

Aged
Aged, 80 and over
Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized
Female
Humans
Intravitreal Injections
Male
Middle Aged
Retreatment
Retrospective Studies
Time Factors
Treatment Outcome
Vascular Endothelial Growth Factor A
Visual Acuity
Wet Macular Degeneration

Access to Document

10.1111/j.1755-3768.2011.02268.x

Cite this

@article{2eece652a95e43ee9eef3336e26823db,

title = "Predictors of 1-year visual outcome in neovascular age-related macular degeneration following intravitreal ranibizumab treatment",

abstract = "To describe predictors of visual outcome in patients treated with intravitreal ranibizumab for choroidal neovascularisation (CNV) in age-related macular degeneration (AMD).",

keywords = "Aged, Aged, 80 and over, Angiogenesis Inhibitors, Antibodies, Monoclonal, Humanized, Female, Humans, Intravitreal Injections, Male, Middle Aged, Retreatment, Retrospective Studies, Time Factors, Treatment Outcome, Vascular Endothelial Growth Factor A, Visual Acuity, Wet Macular Degeneration",

author = "Bloch, {Sara B} and {la Cour}, Morten and Birgit Sander and Hansen, {Louise K H} and Josefine Fuchs and Henrik Lund-Andersen and Michael Larsen",

note = "{\textcopyright} 2011 The Authors. Acta Ophthalmologica {\textcopyright} 2011 Acta Ophthalmologica Scandinavica Foundation.",

year = "2013",

month = feb,

doi = "10.1111/j.1755-3768.2011.02268.x",

language = "English",

volume = "91",

pages = "42--7",

journal = "Acta Ophthalmologica",

issn = "1755-375X",

publisher = "Wiley-Blackwell Munksgaard",

number = "1",

}

TY - JOUR

T1 - Predictors of 1-year visual outcome in neovascular age-related macular degeneration following intravitreal ranibizumab treatment

AU - Bloch, Sara B

AU - la Cour, Morten

AU - Sander, Birgit

AU - Hansen, Louise K H

AU - Fuchs, Josefine

AU - Lund-Andersen, Henrik

AU - Larsen, Michael

PY - 2013/2

Y1 - 2013/2

N2 - To describe predictors of visual outcome in patients treated with intravitreal ranibizumab for choroidal neovascularisation (CNV) in age-related macular degeneration (AMD).

AB - To describe predictors of visual outcome in patients treated with intravitreal ranibizumab for choroidal neovascularisation (CNV) in age-related macular degeneration (AMD).

KW - Aged

KW - Aged, 80 and over

KW - Angiogenesis Inhibitors

KW - Antibodies, Monoclonal, Humanized

KW - Female

KW - Humans

KW - Intravitreal Injections

KW - Male

KW - Middle Aged

KW - Retreatment

KW - Retrospective Studies

KW - Time Factors

KW - Treatment Outcome

KW - Vascular Endothelial Growth Factor A

KW - Visual Acuity

KW - Wet Macular Degeneration

U2 - 10.1111/j.1755-3768.2011.02268.x

DO - 10.1111/j.1755-3768.2011.02268.x

M3 - Journal article

C2 - 22008284

SN - 1755-375X

VL - 91

SP - 42

EP - 47

JO - Acta Ophthalmologica

JF - Acta Ophthalmologica

IS - 1

ER -

Predictors of 1-year visual outcome in neovascular age-related macular degeneration following intravitreal ranibizumab treatment

Abstract

Keywords

Access to Document

Fingerprint

Cite this